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ABSTRACT
The case was 52-year-old female with type 2 diabetes mellitus (T2DM) for 10-years. She complained of  the decreased sensation of  
right lower foot, and revealed diabetic foot infection (DFI) and/or diabetic foot osteomyelitis (DFO) at right 1st proximal phalanx. 
Various data included body mass index (BMI) 33.3 kg/m2, HbA1c 11.4%, blood glucose 430 mg/dL, WBC 12100 /μL, C-reactive 
Protein (CRP) 13.5 mg/dL. On admission (day 1), she was started by 4 times of  injection (Aspart and Glargin) with glucose profile 
200-500 mg/dL. Surgical amputation of  the right toe was performed between 1st metatarsal and proximal phalanx (day 17). Then, 
blood glucose profile decreased moderately. After discharge of  the hospital, super-Low Carbohydrate Diet (LCD) was started with-
out Aspart (day 37). Consequently, glucose profile was normalized with HbA1c 6.3% on (day 77). Consequently, LCD was evaluated 
to be effective for glucose variability in this case and some related discussion was described.
Keywords
Diabetic foot infection (DFI); Diabetic foot osteomyelitis (DFO); Low Carbohydrate Diet (LCD); Japanese LCD promotion 
association (JLCDPA); International Working Group on the Diabetic Foot (IWGDF).
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DFI: Diabetic foot infection; DFO: Diabetic foot osteomyelitis; LCD: Low carbohydrate diet; JLCDPA: Japanese LCD promotion 
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INTRODUCTION
Diabetes mellitus is chronic and crucial non-communicable disease (NCV) across the world.1 It may give various influ-
ence in social, medical and economic aspects.2 Then, some dia-
betic standard guidelines were presented for adequate diagnosis 
and treatment for better glycemic control.2 Chronic complications 
related to diabetes mellitus include both microvascular and mac-
rovascular influences.1 Among them, a variety of  mechanism has 
been involved in the development and aggravation of  macroangi-
opathy, including vascular damage, neuronal dysfunction, intersti-
tial injury, metabolic damage and others.1
 Diabetes mellitus brings more incidence of  various dia-
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betic complications of  foot.3 Among them, diabetic foot infection 
(DFI) has been crucial problem for actual diabetic practice. The 
reason includes persisting infection for long, necessary frequent 
visits, treatment of  antibiotics, daily wound care, sometimes surgi-
cal procedures.4
 DFI has been one of  the macroangiopathy and compli-
cation to be necessary for hospitalization.5 It may show complex 
clinical course, with several exacerbation such as the amputation 
of  lower extremities and economically high health costs.4 When 
patients have some degree of  DFI, the prognosis would be poor 
from several reports.6 According to a prospective study, the prog-
nosis of  DFI showed that foot ulcer healed in 46% at 1-year, 15% 
of  patients were dead and 17% had the amputation of  lower ex-
tremity.6 
 For clinical practice and research of  diabetes, the topic 
concerning DFI has been frequently discussed for long.7 Further, 
physicians majoring on diabetes pay attention to the prevention of  
DFI for long.7
 On the other hand, the basic treatment of  diabetes has 
been adequate diet. In recent years, the transition tendency has 
been found from the calorie restriction (CR) to low carbohydrate 
diet (LCD). LCD was formerly started by Bernstein and Atkins 
in the health and medical fields.8 Clinical effect was reported in 
comparison with CR and Mediterranean diet.9 After that, lots of  
comparison reports were found resulting in the predominant ef-
ficacy of  LCD.10 Then, LCD has been more prevalent in European 
and North American region. 
 In Japan, the authors and colleagues have initiated the 
method of  LCD, and developed LCD movement through Japa-
nese LCD Promotion Association (JLCDPA).11 We have continued 
clinical research on LCD such as the comparison of  blood glucose 
profiles in CR and LCD, Morbus (M) value, continuous glucose 
monitoring (CGM), meal tolerance test (MTT), elevated ketone 
bodies in the axis of  fetus, placenta, pregnant mother and new-
born, and so on.12-14 We have proposed three types of  LCD meal 
pattern for everyone to understand LCD well and continue LCD 
easily. They are petite-, standard-, super-LCDs with 40%, 26%, 
12% of  carbohydrate ratio included.15,16 
 As mentioned above, we have continued clinical research 
on diabetic patients with various problems. Among them, there 
was a diabetic case who had diabetic foot osteomyelitis (DFO) in 
the category of  DFI, operation of  osteotomy and satisfactory ef-
fect on LCD. In this article, the impressive and suggestive case 
would be reported and discussed.
CASE REPORT
Present History
The case was 52-year-old female patient with T2DM for 10-years 
of  duration. She had received the treatment of  oral hyperglyce-
mic agents (OHA) without no history of  insulin treatment. For 
last 6-months, she had not treated enough for the diabetic control. 
During this period, her HbA1c value was persisted around 11-12% 
for half  year. She had an outpatient consultation in January, 2020. 
At that time, she complained of  the decreased sensation of  right 
lower foot. Rapid exam of  blood glucose and HbA1c revealed 430 




Her physicals were as follows: consciousness was alert, the vitals 
were pulse 76/min, BP 187/90 mmHg, SpO 2 98%, BT 36.8 °C, res-
piration was normal, body weight 73 kg, stature 148 cm, body mass 
index (BMI) 33.3 kg/m2, unremarkable of  lung, heart, abdomen. 
Her neurological reflexes of  patellar (PTR) and Ankle (ATR) were 
decreased. There was remarkable change in the right 1st toe, which 
was a diabetic ulcer to gangrene in moderate to severe degree (DFO). 
This situation was evaluated to treat as soon as possible for save her 
life. Then, she was admitted to the hospital for further evaluation 
and treatment for the hyperglycemia and DFO in the right 1st toe. 
Laboratory Test
 
Laboratory tests on the first visit were performed. The standard 
peripheral blood and biochemical data were: WBC 12100 /μL, 
RBC 4.72×106/μL, Hb 13.0 g/dL, PLT 34.9×104/μL, C-reactive 
protein (CRP) 13.5 mg/dL (5+), blood glucose 453 mg/dL, C-
peptide 4.1 ng/mL (0.8-2.5), AST 13U/L, ALT 14 U/L, r-GT 35 
U/L, ALP 338 U/L (104-338), LDH 197 U/L (106-211), T-Bil 0.4 
mg/dL, CPK 50 U/L (30-200), BUN 15 mg/dL, Creatinine 0.6 




She received fundamental screening for several tests. Chest X-ray 
and electrocardiogram (ECG) were negative. Abdominal X-ray 
was unremarkable. Abdominal CT scan showed fatty liver. X-ray 
of  right foot showed that right 1st proximal phalanx was dam-
aged due to severe degree as osteomyelitis, and 1st metatarsal was 
unremarkable. Urinalysis showed that glucose (3+), protein (2+), 
urobilinogen (+). In ophthalmic detail examination, she has vague 
visual function with bilateral proliferative retinopathy. Her intra-
ocular pressure was RT 23 mmHg, LT 18 mmHg. She showed that 
RV=0.08 (0.3x-1.25D)=CYL -2.75 DAX 50°, LV=0.1 (0.4x-2.25 
D)=CYL -1.25 DAX 90°.
 
Diagnosis and Problem Lists
 
According to her medical history, she had not been treated diabe-
tes enough for half  year. Such situation has brought her current 
distress situation. She was diagnosed as the following problem lists. 
They were #1: Type 2 diabetes mellitus (T2DM), #2: osteomyelitis 
of  1st proximal phalanx in the right foot (DFO), #3 obesity (BMI 
33.3), #4: hypertension, #5, diabetic neuropathy, #6 diabetic pro-
liferative retinopathy, #7 diabetic nephropathy.
 Concerning #1 and #3 mentioned above, her long his-
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tory will be summarized. The body weight was 52 kg at 20-years 
old (yo) and 64 kg at 24 yo. She kept weight about 50 kg for a while 
after marriage. After that, she came back to working as a nurse, and 
gradually increased up to 68 kg at 40 yo and 75 kg at 50 yo. The 
weight was 73 kg at this first visit (53 yo). Diabetes was pointed 




She has diagnosed to have osteomyelitis in the right 1st phalanx. 
According to the result of  the culture from the infected area, de-
tected bacteria was Streptococcus agalactiae (B group) (++). Then, 
sensitive kind of  antibiotics was selected and the case was given 
cefmetazole sodium (D00911) 2 g per day, and continued. On the 
5th day after admission, the data were rather improved with WBC 
8800/μL, Hb 12.4 g/dL, CRP 1.5 mg/dL (++).
Nutritional Therapy
 
As for the nutritional therapy for diabetes, she was on the diabetes 
meal regimen for modified protocol of  regular Japanese standard 
meal for CR by Japan Diabetes Association (JDA).17 JDA has pro-
posed 50-60% of  carbohydrate ratio of  total energy per day, but 
our hospital has modified diabetic meal with 40% of  carbohydrate 
ratio. 
 The detail of  the meal and its calculation methods were 
as follows: i) stature of  the case was 148 cm, then standard body 
weight becomes 48.2 kg (1.48×1.48×22=48.2), ii) standard calorie 
per day becomes 1205 kcal/day with (48.2 kg×25 kcal/kg=1205 
kcal/day) (25 kcal/kg means sedentary lifestyle in the hospital), iii) 
the meal per day included 1250 kcal, protein 50 g, fat 48 g, carbo-
hydrate 125 g, NaCl 7 g, water more than 1500 ml.
Table 1. Changes in Daily Profile of Blood Glucose Before and After the Operation
Month Date Day
Daily Profile of Blood Glucose
(mg/dL)
Aspart Glargine
700 h 1100 h 1700 h
2100 h
3 times once





21 2 396 524 378 273 26 6
22 3 263 359 313 367 32 7
24 5 196 343 251 234 29 8
27 8 172 256 238 233 29 9
30 11 190 231 220 225 28 10
February
2 14 161 202 140 242 24 10
5 17
Operation
202 239 167 129 29 10
6 18 136 185 193 128 26 10
7 19 154 153 125 183 26 10
10 22 185 155 137 144 26 10
14 26 142 176 125 118 22 10
18 30 128 170 141 134 22 10
24 36 159 102 127 105 22 10
25 1
Discharge
126 150 130 131 22 10
26 2 132 142 133 143 0 10
27 3 110 132 122 138 110 162 154 0 10
29 5 117 119 145 123 158 147 0 8
March
2 7 116 151 127 135 162 148 149 0 8
5 10 106 140 107 144 113 141 113 0 6
10 15 112 150 154 136 0 6
15 20 132 207 160 169 166 0 4
25 25 142 164 125 127 120 0 4
26 31 110 133 136 169 149 0 0
31 36 114 166 116 118 0 0
April 12 48 133 118 114 106 0 0
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Insulin Treatment
 
She has started ACE Self-Assessment Program (ASAP) multiple 
daily insulin injection (MDI) with four times of  insulin per day. 
She was given 2 kinds of  insulin. One is Novo rapid (Novo Nord-
isk, Bagsværd, Denmark) three times a day just before three meals. 
Another is insulin Glargine (Eli Lilly and Company, Indiana, USA) 
at night at 2100 h. These two kinds in brand names were Insulin 
Aspart by pre-filled pen with 100 units/mL, and Insulin Glargine 
by BS injection kit FFP with 300 units/mL.
 In this case, the control of  blood glucose and insulin 
administration were shown in Table 1. The doses of  Novo rapid 
three times a day were decided by the sliding scale method, accord-
ing to the pre-prandial blood glucose before three meals. We used 
two kinds of  sliding scale methods, which were middle degree and 
high degree. Due to 8 levels of  blood glucose [<100, 101-, 151-, 
201-, 251-, 301-, 351-, 401<mg/dL], the former indicates insulin 
doses [0, 4, 6, 9, 12, 14, 16, 19 units] and the latter indicates insulin 
doses [2, 6, 10, 12, 14, 16, 18, 21 units] by insulin aspart. High de-
gree was used from day 4 to day 16 after admission. 
 Table 1 (upper) showed the changes in blood glucose 
after admission. From admission to the operation, the profile 
of  blood glucose profile during day 1-10 revealed higher values 
(Table 1, upper). They were almost 200-500 mg/dL and gradually 
decreased from day 11-17. After the operation, glucose profile de-




The general status and DFO were gradually improved. On 17th day 
from the admission, she received the surgical operation of  an am-
putation at the right toe. The osteotomy was performed between 
1st metatarsal and proximal phalanx (Figure 1). The operation was 
successfully achieved and the progress condition after the opera-
tion showed improvement. After the operation, blood glucose 
showed improvement than before the operation (Table 1, middle). 
After 18-days of  operation, she was discharged from the hospital.
LCD without Insulin
 
Just after the discharge, she started LCD. Daily profile of  blood 
glucose without insulin is shown (Table 1, lower). Postprandial 
blood glucose was checked just after 60-minutes, when the max 
value of  hyperglycemia is usually observed. Without Novo rapid 
insulin, postprandial glucose 1-hour after meal was stable around 
130-160 mg/dL. Her glucose variability persisted satisfactory after 
discharge on day 1-48 (Table 1, lower). 
 After her blood glucose rapidly dropped, there was no 
progression of  retinopathy. She has no hypoglycemic episode so 
far, and her visual acuity has been not changed. Further, the degree 
of  the proteinuria has reduced from ++ to +/-. The blood level 
of  ketone bodies were not determined, and will be followed as the 
meal of  LCD continues.
Changes in HbA1c and Weight
 
Changes in HbA1c value were observed in the following: 11-12% 
during August 2019- December 2019, 11.4% in January 2020, 9.3% 
in February, 8.0% in March, 6.3% in April (Figure 2). Changes in 
body weight were as follows: 72-74 kg during August 2019-Decem-
ber 2019, 73 kg in January 2020, 70 kg in February, 65 kg in March 
and 59 kg in April (Figure 2).
Current Medication
 
During the admission, she was provided insulin treatment. After 
her discharge from the hospital, she discontinued insulin therapy, 
and started metformin 500 mg a day for diabetes mellitus, and Ai-
mix® Combination Tablets LD or HD (amlodipine 5 or 10 mg, 
irbesartan 100 mg) a day for hypertension. After discharge, her 
diabetic and hypertensive condition has been stable without any 
problems.
DISCUSSION AND CONCLUSION
In this article, a diabetic case was presented who suffered from 
Figure 1. X-ray of the Bilateral Feet After the Operation
Figure 2. Changes in HbA1c and Weight Associated with Operation and LCD
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DFI and DFO, received the osteotomy of  right toe, and showed 
remarkable improvement of  glucose variability by LCD. Discus-
sion would be described from some points of  view.
 Firstly, the background of  the patient was a registered 
nurse working hard for years. Possible causes related to current 
serious condition were as follows: i) the work has been irregular 
due to day shift and night shift, ii) the stress of  work was persisted 
for long, iii) necessary care of  her two children at home, iv) gen-
eral malaise from various stresses physically and psychologically, 
v) irregular medications with poor compliance or resilience. These 
factors might become exacerbating influence to the clinical course 
of  this case.
 As regard to her diabetic control, hyperglycemia seemed 
to be continued more than half  a year. During that time, she did 
not have any consciousness disorder due to hyperglycemia, and 
was able to perform normal nurse duties. The body seemed to be 
accustomed to long-term hyperglycemia.
 The weight was probably maintained about the same level 
for half  a year. There were weakened tendon reflexes, impaired 
perception, and neuropathy. As to visual acuity, she cannot hold a 
clear visual field because of  the proliferative retinopathy. She has 
some numbness in hand and foot at the extremities as neuropathy. 
Proteinuria as nephropathy has also persisted. Consequently, the 
existence of  three types of  microangiopathy were bound. On the 
other hand, detail presence of  macroangiopathy would be investi-
gated such as brain, heart, and feet.
 Secondly, the case suffered from DFI. There has been 
some development in the light of  DFI. From international neces-
sity of  management of  DFI, there have been several guidelines. 
The standard one is from International Working Group on the 
Diabetic Foot (IWGDF). It has continuously published the guide-
lines every 4-years since 2004.18 The prevalent edition includes the 
format of  standard content.18 Furthermore, it incorporates neces-
sary information of  systematic reviews about the interventions for 
DFI.19
 Recently, new IWGDF Guideline on the diagnosis and 
treatment of  foot infection for diabetic patient was presented in 
2019.20,21 It has 7 guidelines, which was structured using the pa-
tient-intervention comparison-outcome (PICO) format.22,23 IW-
GDF has also produced systematic review on DFO.22 In 2019 up-
dated IWGDF guideline is supported by reviews for diagnosis24 
and interventions of  DFI.25
 For current case, Streptococcus was identified in bacte-
rial culture from an infected wound on the foot. There are known 
studies of  this in foot infections for diabetes. In the category of  
DFI, rather severe DFO is present. Regarding DFO, narrative re-
view was conducted, in which 65 papers were included from 756 
related reports.26 Formerly in the pre-antibiotic era, DFO by staph-
ylococcus had 50% of  mortality. Recent situation shows usually 
polymicrobial with gram-negative and positive bacilli can be identi-
fied by the modern molecular techniques.26 
 Regarding the epidemiology for osteomyelitis, DFO 
shows rarely mono-microbial organism. There are often polymi-
crobial results, including Staphylococcus aureus (at most 50%), Staphy-
lococcus epidermidis (around 25%), Streptococci (around 30%) and 
Enterobacteriaceae (at most 40%). These bacteria have been usually 
detected in DFO.18,27 In contrast, the proportion of  the anaerobes 
has been usually low. Gram negative bacteria usually include Esch-
erichia coli, Klebsiella pneumoniae and Proteus, and Pseudomonas aerugi-
nosa.18,27
 Long-term prospective study was conducted for limb 
amputation and mortality after the first neuropathic diabetic foot 
ulcer (DFU).28 Subjects were 2880 patients with neuropathic DFU 
group (DFU) and diabetic patients without DFU group (nDFU), 
and followed-up 14-years. For median follow-up 7-years, death 
rate was 17.4% (n=501) vs 3.1% (n=89).28 The 5-/10-year mortal-
ity was 22%/71% with survival of  7.72-years, in DFU group, while 
3%/5% with 12.6-years in nDFU group (all showed significant dif-
ference). DFU group showed 29.3% of  limb amputations. Odd ra-
tio (OR) was 1.31 in DM duration >10-years, 1.47 in nephropathy, 
1.85 in minor amputation, 2.96 in major amputation, respectively, 
which could predict mortality.28 
 Thirdly, an impressive clinical course was found associat-
ed with DFI and/or DFO. After admission, blood glucose control 
was performed by the sliding scale method. Although the sliding 
scale method revealed stronger level than usual, the blood glucose 
level remained high at around 200-500 mg/dL during continuous 
administration of  insulin. Blood glucose control had been resis-
tant, and its cause seemed to be due to strong inflammatory state 
from foot infection. 
 After the operation, the daily profile of  blood glucose 
became rapidly stable. Preprandial glucose was 100-200 mg/dL. 
This process was supposed to be from reduced inflammatory state 
from DFO. As to the changes in CRP value, it decreased to 13.5 
mg/dL (day 1) was decreased to, 1.5 mg/dL (day 6) and 1.5 mg/dL 
(day 10). There are reports on the extent of  CRP increase. 
 In the clinical diabetic practice, differential diagnosis of  
osteomyelitis and soft-tissue infection has been clinically impor-
tant.29 Because the former needs the possibility of  more antibiotic 
administration, operation and amputation. For distinguishing os-
teomyelitis, optimal cut off  values for ESR and CRP were inves-
tigated. The threshold of  60 mm/h in ESR showed sensitivity of  
74% sensitivity and specificity of  56%. In contrast, threshold of  
7.9 mg/dL in CRP had 49% sensitivity and 80% specificity.29
 Fourthly, clinical effect of  LCD was demonstrated in this 
case. During her stay in the hospital, she was on CR with 125 g 
of  carbohydrate associated with insulin.30 During this period, her 
weight reduction was mild. The reason was that both carbohydrate 
intake and insulin administration were present. On the other hand, 
after discharge from the hospital, neither intake of  sugar nor in-
crease in blood insulin concentration was continued. Therefore, 
body weight seemed to be decreased rapidly.
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 After discharge from the hospital, the meal was switched 
from CR to LCD immediately. During admission, it is difficult to 
cut staple foods for regular meals. On the other hand, outpatients 
can delete carbohydrate food completely, while much amount of  
vegetables and protein can be taken. Therefore, fast-acting Aspart 
insulin was immediately discontinued, and only metformin 500 mg 
was given as oral hyperglycemic agent (OHA). Generally speaking, 
postprandial blood glucose is highest at 30-60-minutes. This case 
showed stable blood glucose level 60 min after meal, indicating 
satisfactory efficacy of  LCD. 
 In this case, the body weight was reduced from 73 kg 
to 59 kg and HbA1c was reduced from 11.4 to 6.3% in less than 
3-months. We have already reported concerning the effect of  
weight reduction by LCD.31 As a result of  LCD for 2699 cases, 
weight loss of  10% or more was observed in 25.6%, and weight 
loss of  5% or more was 57.6%, which showed enough clinical ef-
fect of  LCD. It is effective to teach the LCD method for obese and 
diabetic patients and to continue LCD. We have developed LCD 
movement by English papers, books and seminars through JLCD-
PA. Depending on the situation, petite-, standard-, super-LCD can 
be applied and treated.16,32 
 Regarding the limitations of  this paper, we report on 
the surgical treatment of  foot infection in diabetic patients (DFI, 
DFO) and the effect on LCD. For foot infections, soft tissue can 
be mild and osteomyelitis can be severe. As future work, it may be 
necessary to examine the severity of  infectious diseases, the types 
of  bacteria that cause the infections, the effects of  antimicrobial 
agents, and the response of  other biomarkers. With respect to 
LCDs, it was shown that the increase in postprandial blood glucose 
was suppressed by LCD. Furthermore, detailed intake of  food and 
postprandial blood glucose should be examined in the future.
 In summary, we reported a case of  a diabetic patient who 
underwent surgery for diabetic foot osteomyelitis (DFO) and was 
able to control blood glucose with LCD. We hope that this report 
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